Preclinical data demonstrate deep and durable tumor regressions with lead product candidate ERNA-101 in combination with PD-1 Blockade in ovarian ...

The expansion study comprises two cohorts of nimacimab monotherapy (400 mg IV and 600 mg IV) compared to placebo administered weekly over 15 weeks (16 doses), with a 12 week follow-up period, to ...

Read Daily Current Affairs and GK Updates for 4th April 2026 covering national, international, banking, economy, sports, defence and important news for exams.

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

For 30 years, Delhi has been cracking down on its industrial areas for pollution, shifting them out, and then abandoning them ...

THE logic is always the same. Create a crisis or wait for one. Manufacture desperation, or weaponise it. And then, when a ...

Searching for the perfect Mother’s Day gift? These skincare picks deliver real results and are guaranteed to make mom feel extra loved — trust us, we tested them!

Hollywood High Principal Samuel Dovlatian has shifted the school to operating "like a college," allowing students to choose a ...

VANCOUVER, British Columbia, April 02, 2026--$79 million investment from Government of Canada supports $280 million project ...

Successful initial tests in research for novel AGROBODY bioactive against key insect pestGhent, BELGIUM, April 07, 2026 (GLOBE NEWSWIRE) -- Press release Biotalys (Euronext: BTLS), an Agricultural ...

Potential breakthrough therapeutic targets $50B+ global immunotherapy market1 CHICAGO, March 31, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) ("MAIA", the "Company"), a clin ...